Experimental validation of AS human transcripts by using the retained-intron pattern. (A) RNA expression of retained-intron AS sequences in 20 human tissues (1, adrenal gland; 2, bone marrow; 3, brain, cerebellum; 4, brain, whole; 5, fetal brain; 6, fetal liver; 7, heart; 8, kidney; 9, liver; 10, lung, whole; 11, placenta; 12, prostate; 13, salivary gland; 14, skeletal muscle; 15, testis; 16, thymus; 17, thyroid gland; 18, trachea; 19, uterus and 20, spinal cord). The upper panel exemplifies ‘ubiquitous’ retained-intron AS sequences and the lower panel exemplifies ‘tissue-preferred’ retained-intron AS sequences. (B) RT–PCR analysis using polysomal fractions isolated from the human promyelocytic leukaemia cell line HL60. (C) RNA expression of retained-intron AS sequences mixed with translating ribosome fractions (i.e. polysome fractions) from the HL60 cell line. (D) Number of expressed transcripts in each conserved category.